Symptoms and quality of life at 1-year follow up of patients discharged after an acute COVID-19 episode.


Journal

Swiss medical weekly
ISSN: 1424-3997
Titre abrégé: Swiss Med Wkly
Pays: Switzerland
ID NLM: 100970884

Informations de publication

Date de publication:
06 12 2021
Historique:
entrez: 15 12 2021
pubmed: 16 12 2021
medline: 21 12 2021
Statut: epublish

Résumé

Patients surviving COVID-19 have been described as being at risk of developing sequelae. We aimed to investigate and elicit persistent symptoms, emotional status and quality-of-life in patients discharged after an acute COVID-19 episode. Patient-reported outcome measures were collected during a telephone interview 30 days and 1 year after discharge. Patients' general health status was evaluated using questions based on their symptoms, emotional status was assessed using the items 9 to 12 of the HeartQoL questionnaire and quality of life was assessed at 1 year through the EQ-5D-5L. In patients with a history of cardiovascular disease, all 14 items of the HeartQoL questionnaire were completed to derive the HeartQoL global score. Among 687 patients who survived after being hospitalised for COVID-19 at the University Hospitals of Geneva between 26 February and 26 April 2020, 184 (27%) and 165 (24%), respectively, participated in the follow-up at 30 days and 1 year. Of these 184 participants, 62% were male, median age was 58 years and 21% had a past medical history of cardiovascular disease. At one month after discharge, 61% (113/184) of patients presented fatigue and 28% (52/184) dyspnoea. One year after discharge, the main complaints were persistent fatigue in 27% (45/165) of patients, neurological problems in 17% (28/165) and dyspnoea in 14% (23/165). Eight percent (14/184) of patients declared being significantly worried 1 month after discharge and 5% (9/184) feeling depressed. The number of patients reporting being significantly worried or depressed at 1 year was lower. Regarding the quality of life at 1 year, the median EQ-5D-5L visual analogue scale score was 80 (interquartile range 70-90). Approximately half of patients reported some symptoms 1 year after discharge following an acute episode of COVID-19. The predominant symptom was persistent fatigue both at 1-month and at 1-year follow-up. Emotional status and quality of life appeared satisfactory.

Identifiants

pubmed: 34909433
doi: 10.4414/smw.2021.w30093
pii: Swiss Med Wkly. 2021;151:w30093
doi:
pii:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

w30093

Auteurs

Elena Tessitore (E)

Department of Internal Medicine, Division of Cardiology, University Hospitals of Geneva, Switzerland.

Sandra Handgraaf (S)

Department of Internal Medicine, Division of Cardiology, University Hospitals of Geneva, Switzerland.

Antoine Poncet (A)

Department of Health and Community Medicine, University Hospitals of Geneva, Switzerland.

Maëlle Achard (M)

Department of Internal Medicine, Division of Cardiology, University Hospitals of Geneva, Switzerland.
Faculty of Medicine, University of Geneva, Switzerland.

Stefan Höfer (S)

Department of Medical Psychology, Innsbruck Medical University, Innsbruck, Austria.

Sebastian Carballo (S)

Department of Internal Medicine, Division of Internal Medicine, University Hospitals of Geneva, Switzerland.

Christophe Marti (C)

Department of Internal Medicine, Division of Internal Medicine, University Hospitals of Geneva, Switzerland.

Cédric Follonier (C)

Department of Internal Medicine, Division of Cardiology, University Hospitals of Geneva, Switzerland.
Faculty of Medicine, University of Geneva, Switzerland.

François Girardin (F)

Service of Clinical Pharmacology, Department of Laboratory Medicine and Pathology, Lausanne University Hospital (CHUV) and University of Lausanne, Switzerland.
Department of Anaesthesiology, Clinical Pharmacology, Intensive Care and Emergency Medicine, Division of Clinical Pharmacology and Toxicology, University Hospitals of Geneva, Switzerland.

François Mach (F)

Department of Internal Medicine, Division of Cardiology, University Hospitals of Geneva, Switzerland.

David Carballo (D)

Department of Internal Medicine, Division of Cardiology, University Hospitals of Geneva, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH